Actinium Pharmaceuticals (ATNM) Payables (2010 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Payables of $6.6 million for Q1 2026, up 1.46% year-over-year from $6.5 million in Q1 2025, and down 8.72% quarter-over-quarter from $7.2 million in Q4 2025.
Actinium Pharmaceuticals (ATNM) Payables (2010 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Payables for 17 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 1.46% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (up 1.46% YoY), while the FY2025 annual figure was $7.2 million, down 4.24% from the prior year.
- Payables slipped to $6.6 million in Q1 2026 per ATNM's latest filing, from $7.2 million in the prior quarter.
- Across five years, Payables topped out at $15.9 million in Q4 2023 and bottomed at $5.3 million in Q1 2022.
- Historically, Payables has averaged $7.9 million across 5 years, with a median of $7.5 million in 2024.
- Annual changes were most pronounced in 2022 — Payables surged 108.56% — and 2024, when it tumbled 52.42%.
- Actinium Pharmaceuticals' Payables stood at $10.1 million in 2022, then soared by 57.02% to $15.9 million in 2023, then sank by 52.42% to $7.6 million in 2024, then fell by 4.24% to $7.2 million in 2025, then slipped by 8.72% to $6.6 million in 2026.
- Business Quant data shows ATNM's Payables at $6.6 million in Q1 2026, $7.2 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | 8.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.51 Mn |
| Mar 31, 2026 | 6.62 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Jun 30, 2025 | 7.71 Mn |
| Mar 31, 2025 | 6.52 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 15.91 Mn |
| Sep 30, 2023 | 8.15 Mn |
| Jun 30, 2023 | 8.64 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Dec 31, 2022 | 10.13 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 5.26 Mn |
| Dec 31, 2021 | 5.54 Mn |
| Sep 30, 2021 | 3.77 Mn |